The knockout of apolipoprotein M also exacerbated the progression of glomerular disease in an STZ-injected mouse model, while apolipoprotein M overexpression through adenoviral vector injection reduced diabetic nephropathy phenotypes [97]. This evidence concerns the gene APOM and diabetic kidney disease.